Phase 1–2 Trial of Antisense Oligonucleotide Tofersen...

New England Journal of Medicine 2020 / 07 Vol. 383; Iss. 2

Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS

Miller, Timothy, Cudkowicz, Merit, Shaw, Pamela J., Andersen, Peter M., Atassi, Nazem, Bucelli, Robert C., Genge, Angela, Glass, Jonathan, Ladha, Shafeeq, Ludolph, Albert L., Maragakis, Nicholas J., M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
383
Journal:
New England Journal of Medicine
DOI:
10.1056/NEJMoa2003715
Date:
July, 2020
File:
PDF, 917 KB
2020
Conversion to is in progress
Conversion to is failed